ClinVar Miner

Submissions for variant NM_000352.6(ABCC8):c.1923+3G>A

gnomAD frequency: 0.00028  dbSNP: rs374869130
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic RCV002267091 SCV002522309 uncertain significance Transitory neonatal diabetes mellitus criteria provided, single submitter research Mutations in ABCC8 gene are associated with both neonatal diabetes mellitus as well as MODY. Patients with this mutation may have a better response to sulfonylureas. However, no sufficient evidence is found to ascertain the role of this particular variant ( rs374869130) in neonatal diabetes yet.
Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic RCV002267090 SCV002522310 uncertain significance Maturity onset diabetes mellitus in young criteria provided, single submitter research Mutations in ABCC8 gene are associated with both neonatal diabetes mellitus as well as MODY. Patients with this mutation may have a better response to sulfonylureas. However, no sufficient evidence is found to ascertain the role of this particular variant ( rs374869130) in MODY yet.
Fulgent Genetics, Fulgent Genetics RCV002493477 SCV002793708 uncertain significance Diabetes mellitus, transient neonatal, 2; Hyperinsulinemic hypoglycemia, familial, 1; Leucine-induced hypoglycemia; Type 2 diabetes mellitus; Diabetes mellitus, permanent neonatal 3 2021-07-12 criteria provided, single submitter clinical testing
Ambry Genetics RCV002541682 SCV003546435 uncertain significance Inborn genetic diseases 2022-11-15 criteria provided, single submitter clinical testing The c.1923+3G>A intronic alteration consists of a G to A substitution 3 nucleotides after coding exon 13 of the ABCC8 gene. Based on data from the Genome Aggregation Database (gnomAD) database, the ABCC8 c.1923+3G>A alteration was observed in 0.01% (24/282294) of total alleles studied, with a frequency of 0.09% (23/24958) in the African subpopulation. This nucleotide position is not conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV004699258 SCV005204781 uncertain significance not specified 2024-06-17 criteria provided, single submitter clinical testing
Natera, Inc. RCV001278415 SCV001465428 uncertain significance Hereditary hyperinsulinism 2020-04-10 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.